Clinical Trial

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

Name: Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease — clinical trial record (NCT07356050)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: VALID

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)

Trial Details

NCT Number	NCT07356050
Lead Sponsor	Children's Hospital Medical Center, Cincinnati Collaborators: Thrasher Research Fund, National Institutes of Health (NIH)
Conditions	Sickle Cell Disease, Measles Vaccination, Sickle Cell Anemia
Enrollment	130 participants
Start Date	2025-03-13
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-21